Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39393406 for Smoking Cessation in Schizophrenia
NCT02230384Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-39393406 in Tobacco Use Disorder (TUD). Started Sep 2014; status: completed.
02
Drugs
JNJ-39393406
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02230384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230384.